AKERO THERAPEUTICS, INC. - Common Stock (AKRO)

CUSIP: 00973Y108

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Common Stock
Shares outstanding
82,872,659
Total 13F shares
30,844,129
Share change
+1,823,934
Total reported value
$813,955,792
Price per share
$25.80
Number of holders
94
Value change
+$45,233,337
Number of buys
45
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 00973Y108?
CUSIP 00973Y108 identifies AKRO - AKERO THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AKRO - AKERO THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of AKERO THERAPEUTICS, INC. - Common Stock (AKRO) as of Q4 2020

As of 31 Dec 2020, AKERO THERAPEUTICS, INC. - Common Stock (AKRO) was held by 94 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,844,129 shares. The largest 10 holders included ATP Life Science Ventures, L.P., JANUS HENDERSON GROUP PLC, venBio Partners LLC, Redmile Group, LLC, ALKEON CAPITAL MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, HILLHOUSE CAPITAL ADVISORS, LTD., BlackRock Inc., VANGUARD GROUP INC, and BOXER CAPITAL, LLC. This page lists 94 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders
103
Q4 2020 holders
94
Holder diff
-9
Investor Q3 2020 Shares Q4 2020 Shares Share Diff Share Chg % Q3 2020 Value $ Q4 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .